Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys
Share |

Strategies for Marketing Compliance
A Few Thoughts from a Physician's Point of View

According to the analysts at Gartner, it is possible that a life science company will be fined $1 billion for marketing non-compliance this year.

All pharma companies face a communications crisis that rests on the changing role of the medical sales representative. This evolution has a direct impact on the obligations of the pharma marketing organizations to be both proactive and responsive in helping to protect their organizations from the threat of non-compliance.

What can marketing do? This article offers a few thoughts from a physician's point of view, written by Jonathan Sackier, M.B., Ch.B., FRCS, FACS who is a regular blogger at www.goodpromotionalpractices.com.

Topics include:
  • Pharma Behaving Badly
  • Good Corporate Citizens All
  • A "Reasonable" $600 Million Fine
  • TABLE: Top 2010 pharmaceutical and medical device settlements relating to off-label marketing.
  • Will 2011 Be DOJ Fine Free?
  • 4 Strategies for Compliance
  • Close the Gap Caused by Downsizing

Read this article now. It's FREE...

Download PDF file

PMN102-01
Issue: Vol. 10, No. 2: 19 January 2011
Word Count: 959

Find other articles in related Topic Areas:

Vol 10, #2 Contents






Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.